First Trust Advisors LP raised its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 23.7% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 63,684 shares of the company’s stock after buying an additional 12,210 shares during the period. First Trust Advisors LP’s holdings in U.S. Physical Therapy were worth $7,553,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of the company. Atria Investments LLC lifted its holdings in shares of U.S. Physical Therapy by 35.3% during the 3rd quarter. Atria Investments LLC now owns 4,045 shares of the company’s stock worth $480,000 after acquiring an additional 1,055 shares during the last quarter. United Services Automobile Association purchased a new position in U.S. Physical Therapy in the 2nd quarter worth $298,000. Northern Trust Corp raised its position in U.S. Physical Therapy by 10.3% in the 2nd quarter. Northern Trust Corp now owns 217,737 shares of the company’s stock worth $20,903,000 after purchasing an additional 20,295 shares during the period. Public Employees Retirement System of Ohio purchased a new position in U.S. Physical Therapy in the 2nd quarter worth $576,000. Finally, California Public Employees Retirement System raised its position in U.S. Physical Therapy by 3.9% in the 2nd quarter. California Public Employees Retirement System now owns 42,767 shares of the company’s stock worth $4,106,000 after purchasing an additional 1,602 shares during the period. Institutional investors own 98.50% of the company’s stock.

In other U.S. Physical Therapy news, CFO Lawrance W. Mcafee sold 3,100 shares of the business’s stock in a transaction dated Friday, November 2nd. The shares were sold at an average price of $113.29, for a total value of $351,199.00. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Director Mark J. Brookner sold 625 shares of the business’s stock in a transaction dated Friday, September 7th. The shares were sold at an average price of $128.50, for a total transaction of $80,312.50. The disclosure for this sale can be found here. Insiders sold 12,600 shares of company stock worth $1,460,099 in the last 90 days. Corporate insiders own 2.50% of the company’s stock.

USPH stock opened at $117.27 on Friday. U.S. Physical Therapy, Inc. has a 12-month low of $67.85 and a 12-month high of $129.65. The stock has a market capitalization of $1.48 billion, a price-to-earnings ratio of 56.38, a PEG ratio of 4.05 and a beta of 1.19. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.93 and a current ratio of 1.93.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, November 1st. The company reported $0.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.58 by $0.06. U.S. Physical Therapy had a net margin of 5.58% and a return on equity of 17.64%. The firm had revenue of $113.10 million for the quarter, compared to analysts’ expectations of $112.79 million. The company’s revenue was up 9.8% compared to the same quarter last year. As a group, equities analysts predict that U.S. Physical Therapy, Inc. will post 2.56 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 7th. Shareholders of record on Friday, November 9th will be given a $0.23 dividend. This represents a $0.92 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date is Thursday, November 8th. U.S. Physical Therapy’s payout ratio is 44.23%.

A number of equities analysts recently commented on the stock. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $129.00 target price on the stock in a research report on Tuesday, August 7th. Jefferies Financial Group reiterated a “hold” rating and issued a $105.00 target price on shares of U.S. Physical Therapy in a research report on Friday, August 3rd. Cantor Fitzgerald lifted their target price on shares of U.S. Physical Therapy from $103.00 to $107.00 and gave the stock a “neutral” rating in a research report on Friday, November 2nd. TheStreet cut shares of U.S. Physical Therapy from a “b” rating to a “c+” rating in a research report on Friday, November 2nd. Finally, Barrington Research reiterated a “hold” rating on shares of U.S. Physical Therapy in a research report on Friday, August 3rd. Four analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company’s stock. U.S. Physical Therapy currently has a consensus rating of “Buy” and a consensus target price of $113.67.

TRADEMARK VIOLATION NOTICE: This report was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright and trademark law. The original version of this report can be read at https://www.thecerbatgem.com/2018/11/16/first-trust-advisors-lp-has-7-55-million-holdings-in-u-s-physical-therapy-inc-usph.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Further Reading: Cost of Equity For A Business, Investors

Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH).

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.